Dr. John Novak, M.D

NPI: 1619195880
Total Payments
$91,613
2024 Payments
$39,999
Companies
13
Transactions
121
Medicare Patients
1,647
Medicare Billing
$205,898

Payment Breakdown by Category

Other$65,921 (72.0%)
Consulting$14,500 (15.8%)
Travel$7,803 (8.5%)
Food & Beverage$3,241 (3.5%)
Education$147.69 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $50,288 20 54.9%
Honoraria $15,633 11 17.1%
Consulting Fee $14,500 9 15.8%
Travel and Lodging $7,803 36 8.5%
Food and Beverage $3,241 42 3.5%
Education $147.69 3 0.2%

Top Paying Companies

Company Total Records Latest Year
ARGENX US, INC. $38,987 45 $0 (2024)
Amylyx Pharmaceuticals, Inc. $19,799 38 $0 (2024)
MITSUBISHI TANABE PHARMA AMERICA, INC. $15,848 15 $0 (2024)
UCB, Inc. $10,769 13 $0 (2024)
Biohaven Pharmaceuticals, Inc. $5,708 1 $0 (2020)
ITF Pharma, Inc. $194.60 1 $0 (2022)
EDW Pharma, Inc. $105.21 1 $0 (2023)
Biogen, Inc. $75.79 2 $0 (2024)
EMD Serono, Inc. $71.90 1 $0 (2019)
Johnson & Johnson Vision Care, Inc. $17.99 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $39,999 41 ARGENX US, INC. ($20,574)
2023 $32,007 54 Amylyx Pharmaceuticals, Inc. ($17,383)
2022 $13,766 19 ARGENX US, INC. ($13,554)
2021 $11.34 1 Biogen, Inc. ($11.34)
2020 $5,708 1 Biohaven Pharmaceuticals, Inc. ($5,708)
2019 $97.17 3 EMD Serono, Inc. ($71.90)
2018 $23.88 2 Mitsubishi Tanabe Pharma America, Inc. ($12.21)

All Payment Transactions

121 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
12/19/2024 ARGENX US, INC. VYVGART HYTRULO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,000.00 General
Category: Neurology
12/19/2024 ARGENX US, INC. VYVGART HYTRULO (Drug) Travel and Lodging Cash or cash equivalent $158.12 General
Category: Neurology
12/03/2024 ARGENX US, INC. VYVGART HYTRULO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,000.00 General
Category: Neurology
11/19/2024 ARGENX US, INC. VYVGART HYTRULO (Drug) Travel and Lodging Cash or cash equivalent $129.08 General
Category: Neurology
11/19/2024 ARGENX US, INC. VYVGART HYTRULO (Drug) Food and Beverage In-kind items and services $121.84 General
Category: Neurology
11/19/2024 ARGENX US, INC. VYVGART HYTRULO (Drug) Travel and Lodging Cash or cash equivalent $60.00 General
Category: Neurology
11/12/2024 UCB, Inc. Rystiggo (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,680.00 General
Category: Neurology
11/01/2024 MITSUBISHI TANABE PHARMA AMERICA, INC. Consulting Fee Cash or cash equivalent $1,500.00 General
10/29/2024 ARGENX US, INC. VYVGART HYTRULO (Drug) Food and Beverage In-kind items and services $111.23 General
Category: Neurology
10/22/2024 ARGENX US, INC. VYVGART HYTRULO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,500.00 General
Category: Neurology
10/22/2024 ARGENX US, INC. VYVGART HYTRULO (Drug) Travel and Lodging Cash or cash equivalent $162.28 General
Category: Neurology
10/22/2024 ARGENX US, INC. VYVGART HYTRULO (Drug) Food and Beverage In-kind items and services $16.83 General
Category: Neurology
09/25/2024 ARGENX US, INC. VYVGART (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $7,500.00 General
Category: Immunology
09/25/2024 ARGENX US, INC. VYVGART (Drug) Travel and Lodging Cash or cash equivalent $44.00 General
Category: Immunology
09/25/2024 ARGENX US, INC. VYVGART (Drug) Food and Beverage In-kind items and services $21.65 General
Category: Immunology
09/19/2024 ARGENX US, INC. VYVGART HYTRULO (Drug) Travel and Lodging Cash or cash equivalent $167.57 General
Category: Neurology
09/19/2024 ARGENX US, INC. VYVGART HYTRULO (Drug) Food and Beverage In-kind items and services $124.26 General
Category: Neurology
09/19/2024 ARGENX US, INC. VYVGART HYTRULO (Drug) Travel and Lodging Cash or cash equivalent $60.00 General
Category: Neurology
09/12/2024 MITSUBISHI TANABE PHARMA AMERICA, INC. RADICAVA ORS (Drug) Consulting Fee Cash or cash equivalent $1,000.00 General
Category: AMYOTROPHIC LATERAL SCLEROSIS
08/20/2024 UCB, Inc. Zilbrysq (Drug) Consulting Fee Cash or cash equivalent $1,050.00 General
Category: Neurology
08/16/2024 Biogen, Inc. Education In-kind items and services $64.45 General
08/03/2024 ARGENX US, INC. VYVGART (Drug) Food and Beverage In-kind items and services $75.00 General
Category: Immunology
08/03/2024 ARGENX US, INC. VYVGART (Drug) Food and Beverage In-kind items and services $58.76 General
Category: Immunology
08/03/2024 ARGENX US, INC. VYVGART (Drug) Food and Beverage In-kind items and services $50.00 General
Category: Immunology
08/03/2024 ARGENX US, INC. VYVGART (Drug) Food and Beverage In-kind items and services $8.79 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 374 465 $112,336 $44,689
2022 13 436 541 $132,110 $56,973
2021 15 427 526 $123,097 $55,061
2020 16 410 497 $120,116 $49,175
Total Patients
1,647
Total Services
2,029
Medicare Billing
$205,898
Procedure Codes
55

All Medicare Procedures & Services

55 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 57 108 $27,216 $12,607 46.3%
95911 Nerve conduction, 9-10 studies Office 2023 44 44 $18,876 $6,111 32.4%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Office 2023 60 64 $10,752 $4,542 42.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 38 43 $8,041 $3,840 47.8%
95910 Nerve conduction, 7-8 studies Office 2023 33 33 $11,682 $3,684 31.5%
95885 Needle measurement of electrical activity in arm or leg muscles, limited study Office 2023 50 81 $8,586 $3,641 42.4%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 26 26 $9,334 $3,550 38.0%
95909 Nerve conduction, 5-6 studies Office 2023 25 25 $6,725 $2,363 35.1%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 14 14 $5,082 $1,957 38.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 16 16 $4,656 $1,709 36.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 11 11 $1,386 $686.99 49.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 68 118 $29,682 $14,722 49.6%
95911 Nerve conduction, 9-10 studies Office 2022 42 43 $18,447 $7,079 38.4%
95885 Needle measurement of electrical activity in arm or leg muscles, limited study Office 2022 66 100 $10,600 $4,851 45.8%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Office 2022 57 59 $9,912 $4,512 45.5%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 28 28 $10,052 $4,286 42.6%
95910 Nerve conduction, 7-8 studies Office 2022 32 32 $11,328 $4,195 37.0%
99291 Critical care, first 30-74 minutes Facility 2022 14 20 $8,060 $3,437 42.6%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 21 21 $7,623 $3,132 41.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 31 33 $6,171 $2,738 44.4%
95909 Nerve conduction, 5-6 studies Office 2022 28 28 $7,532 $2,735 36.3%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 19 28 $5,992 $2,259 37.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 17 17 $4,947 $2,105 42.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 13 14 $1,764 $921.61 52.2%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 61 107 $26,802 $13,777 51.4%

About Dr. John Novak, M.D

Dr. John Novak, M.D is a Neurology healthcare provider based in Westerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1619195880.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Novak, M.D has received a total of $91,613 in payments from pharmaceutical and medical device companies, with $39,999 received in 2024. These payments were reported across 121 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($50,288).

As a Medicare-enrolled provider, Novak has provided services to 1,647 Medicare beneficiaries, totaling 2,029 services with total Medicare billing of $205,898. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Other Specialties Clinical Neurophysiology
  • Location Westerville, OH
  • Active Since 04/23/2007
  • Last Updated 08/02/2024
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1619195880

Products in Payments

  • VYVGART (Drug) $22,203
  • RELYVRIO (Drug) $19,799
  • RADICAVA (Drug) $12,836
  • VYVGART HYTRULO (Drug) $10,611
  • Zilbrysq (Drug) $8,935
  • Rystiggo (Drug) $1,680
  • RADICAVA ORS (Drug) $1,500
  • Tiglutik (Drug) $194.60
  • TIGLUTIK (Drug) $105.21
  • Acuvue (Device) $17.99
  • Reveal LINQ (Device) $14.30
  • Radicava (Drug) $12.21
  • AIMOVIG (Biological) $11.67
  • SPINRAZA (Biological) $11.34
  • Trilogy 100 (Device) $10.97

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Westerville